1. Home
  2. YMAB vs BEEP Comparison

YMAB vs BEEP Comparison

Compare YMAB & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • BEEP
  • Stock Information
  • Founded
  • YMAB 2015
  • BEEP 2015
  • Country
  • YMAB United States
  • BEEP United States
  • Employees
  • YMAB N/A
  • BEEP N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • BEEP Blank Checks
  • Sector
  • YMAB Health Care
  • BEEP Finance
  • Exchange
  • YMAB Nasdaq
  • BEEP Nasdaq
  • Market Cap
  • YMAB 192.4M
  • BEEP 162.0M
  • IPO Year
  • YMAB 2018
  • BEEP N/A
  • Fundamental
  • Price
  • YMAB $4.36
  • BEEP $4.20
  • Analyst Decision
  • YMAB Buy
  • BEEP Strong Buy
  • Analyst Count
  • YMAB 11
  • BEEP 2
  • Target Price
  • YMAB $17.55
  • BEEP $6.75
  • AVG Volume (30 Days)
  • YMAB 202.0K
  • BEEP 118.1K
  • Earning Date
  • YMAB 08-11-2025
  • BEEP 08-12-2025
  • Dividend Yield
  • YMAB N/A
  • BEEP N/A
  • EPS Growth
  • YMAB N/A
  • BEEP N/A
  • EPS
  • YMAB N/A
  • BEEP N/A
  • Revenue
  • YMAB $88,658,000.00
  • BEEP $36,416,000.00
  • Revenue This Year
  • YMAB N/A
  • BEEP $5.22
  • Revenue Next Year
  • YMAB $15.15
  • BEEP $5.13
  • P/E Ratio
  • YMAB N/A
  • BEEP N/A
  • Revenue Growth
  • YMAB 4.92
  • BEEP 13.81
  • 52 Week Low
  • YMAB $3.55
  • BEEP $2.48
  • 52 Week High
  • YMAB $16.11
  • BEEP $4.86
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 45.29
  • BEEP 57.32
  • Support Level
  • YMAB $4.10
  • BEEP $4.30
  • Resistance Level
  • YMAB $4.62
  • BEEP $4.67
  • Average True Range (ATR)
  • YMAB 0.29
  • BEEP 0.23
  • MACD
  • YMAB -0.04
  • BEEP 0.01
  • Stochastic Oscillator
  • YMAB 20.73
  • BEEP 62.03

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.

Share on Social Networks: